Journal
NATURE NEUROSCIENCE
Volume 19, Issue 12, Pages 1599-1609Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nn.4421
Keywords
-
Categories
Funding
- National Multiple Sclerosis Society [RG4536, RG4723]
- NIH [R01MH096979, P41EB015897]
Ask authors/readers for more resources
Inflammation induced by innate immunity influences the development of T cell-mediated autoimmunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). We found that strong activation of innate immunity induced Nod-like receptor protein 3 (NLRP3) inflammasome-independent and interferon-beta (IFN beta-resistant EAE (termed type B EAE), whereas EAE induced by weak activation of innate immunity requires the NLRP3 inflammasome and is sensitive to IFN beta treatment. Instead, an alternative inflammatory mechanism, including membrane-bound lymphotoxin-beta receptor (LT beta R) and CXC chemokine receptor 2 (CXCR2), is involved in type B EAE development, and type B EAE is ameliorated by antagonizing these receptors. Relative expression of LTBR and CXCR2 genes was indeed enhanced in patients with IFN beta-resistant multiple sclerosis. Remission was minimal in type B EAE due to neuronal damages induced by semaphorin 6B upregulation on CD4+ T cells. Our data reveal a new inflammatory mechanism by which an IFN beta-resistant EAE subtype develops.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available